Is Mindfulness useful for ADHD?

Not Applicable

• Conditions: Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined typeHealth Condition 2: F908- Attention-deficit hyperactivity disorder, other typeHealth Condition 3: F901- Attention-deficit hyperactivity disorder, predominantly hyperactive typeHealth Condition 4: F900- Attention-deficit hyperactivity disorder, predominantly inattentive typeHealth Condition 5: F909- Attention-deficit hyperactivity disorder, unspecified type

• Registration Number: CTRI/2022/11/047079
• Lead Sponsor: Aishwarya L Solanki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Meets the primary diagnosis of ADHD based on structured (KSAD-PL) and semi structured interviews.

Minimum Score of falling on the 90th percentile or above on the ADHD RS V

If on medication, the medications should be stabilized for 8 weeks prior to entry into the study or drug naive (stabilized-no changes in medication for the past 8 weeks.)

Aged 13 to 17

Functional knowledge of English, Kannada, or Hindi

Exclusion Criteria

Developmental Disorders like autism spectrum disorder, clinical evidence of IDD, conduct disorders, Serious Mental Illnesses like: Bipolar Affective Disorder, Schizophrenia, or Schizoaffective disorders or Traumatic brain injuries/other neurological illnesses.

10

Medical/physiological disability that may hinder their capacity to participate in interviews or interventionsParticipants who have undergone more than 6 sessions of Cognitive Behavior Therapy, Dialectical Behavior Therapy, Interpersonal Therapy, Motivational Enhancement Therapy, or Mindfulness Based Intervention/Training in the past three months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptom severity of ADHD as measured by Attention Deficit Hyperactivity Disorder Rating Scale-V (ADHD-RS V) and Clinical Global Impression ScaleTimepoint: Baseline, Completion of intervention, and 3months

Secondary Outcome Measures

Name	Time	Method
Severity of difficulties in emotional regulation, executive functioning, and other functional areas. <br/ ><br>Timepoint: Baseline, Completion, Three months